Xavier Trinidad Reveles is Chief Operating Officer of bioAffinity Technologies, Inc.. Currently has a direct ownership of 41,943 shares of BIAF, which is worth approximately $31,876. The most recent transaction as insider was on Jan 10, 2025, when has been sold 21,604 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.9K
106.22% 3M change
106.22% 12M change
Total Value Held $31,876

Xavier Trinidad Reveles Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
BUY
Grant, award, or other acquisition
-
21,604 Added 34.0%
41,943 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
16,720 Added 45.12%
20,339 Common Stock
XTR

Xavier Trinidad Reveles

Chief Operating Officer
San Antonio,, TX

Track Institutional and Insider Activities on BIAF

Follow bioAffinity Technologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF